Cargando…

Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2

Detalles Bibliográficos
Autores principales: Guo, Liping, Liu, Xue, Gu, Yuchen, Jiang, Jinyan, Yang, Ziyue, Lv, Qiuying, Guo, Deyin, Yang, Yang, Lu, Hongzhou, Yuan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132431/
https://www.ncbi.nlm.nih.gov/pubmed/37100801
http://dx.doi.org/10.1038/s41392-023-01443-2
_version_ 1785031386186383360
author Guo, Liping
Liu, Xue
Gu, Yuchen
Jiang, Jinyan
Yang, Ziyue
Lv, Qiuying
Guo, Deyin
Yang, Yang
Lu, Hongzhou
Yuan, Jing
author_facet Guo, Liping
Liu, Xue
Gu, Yuchen
Jiang, Jinyan
Yang, Ziyue
Lv, Qiuying
Guo, Deyin
Yang, Yang
Lu, Hongzhou
Yuan, Jing
author_sort Guo, Liping
collection PubMed
description
format Online
Article
Text
id pubmed-10132431
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101324312023-04-27 Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2 Guo, Liping Liu, Xue Gu, Yuchen Jiang, Jinyan Yang, Ziyue Lv, Qiuying Guo, Deyin Yang, Yang Lu, Hongzhou Yuan, Jing Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-04-26 /pmc/articles/PMC10132431/ /pubmed/37100801 http://dx.doi.org/10.1038/s41392-023-01443-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Guo, Liping
Liu, Xue
Gu, Yuchen
Jiang, Jinyan
Yang, Ziyue
Lv, Qiuying
Guo, Deyin
Yang, Yang
Lu, Hongzhou
Yuan, Jing
Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
title Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
title_full Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
title_fullStr Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
title_full_unstemmed Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
title_short Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
title_sort distinct and relatively mild clinical characteristics of sars-cov-2 ba.5 infections against ba.2
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132431/
https://www.ncbi.nlm.nih.gov/pubmed/37100801
http://dx.doi.org/10.1038/s41392-023-01443-2
work_keys_str_mv AT guoliping distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT liuxue distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT guyuchen distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT jiangjinyan distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT yangziyue distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT lvqiuying distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT guodeyin distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT yangyang distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT luhongzhou distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2
AT yuanjing distinctandrelativelymildclinicalcharacteristicsofsarscov2ba5infectionsagainstba2